Real Cancer Stories: Janet Schurmann

Real Cancer Stories: Janet Schurmann

04:10 |

Related Videos

Setting Up Your Expectations For Having Myeloma

Setting Up Your Expectations For Having Myeloma

Overview of HealthTree Programs for Multiple Myeloma

Overview of HealthTree Programs for Multiple Myeloma

HealthTree Podcast for Multiple Myeloma: Dr. Rodger Tiedemann, UHN

HealthTree Podcast for Multiple Myeloma: Dr. Rodger Tiedemann, UHN

HealthTree Study: Dexamethasone's Impact on Eye Health in Myeloma | Rahul Banerjee, MD | IMS 2024

HealthTree Study: Dexamethasone's Impact on Eye Health in Myeloma | Rahul Banerjee, MD | IMS 2024

HealthTree Podcast for Multiple Myeloma: Dr. Sergio Giralt, MSKCC

HealthTree Podcast for Multiple Myeloma: Dr. Sergio Giralt, MSKCC

The Current Standard of Care in the Post-Transplant Setting | Fredrik Schjesvold, MD, PhD | IMS 2024

The Current Standard of Care in the Post-Transplant Setting | Fredrik Schjesvold, MD, PhD | IMS 2024

The Future of Myeloma Drug Development | Dickran Kazandjian, MD

The Future of Myeloma Drug Development | Dickran Kazandjian, MD

How Personalized Is Myeloma Treatment and How Is Changing? Introducing the Individual Risk Model

How Personalized Is Myeloma Treatment and How Is Changing? Introducing the Individual Risk Model

Comparing Outcomes in Younger Multiple Myeloma Patients | Marc Braunstein, MD, PhD | #ASH24

Comparing Outcomes in Younger Multiple Myeloma Patients | Marc Braunstein, MD, PhD | #ASH24

An Introduction to HealthTree for Multiple Myeloma

An Introduction to HealthTree for Multiple Myeloma

$DREAMM‑3 - Blenrep (Belmaf) Vs PomDex For Relapsed/Refractory Myeloma | Katja Weisel, MD | ASCO 2023$

DREAMM‑3 - Blenrep (Belmaf) Vs PomDex For Relapsed/Refractory Myeloma | Katja Weisel, MD | ASCO 2023

CAR-T Therapy, CARTITUDE-1 ciltacabtagene autoleucel in RRMM Patients | Yi Lin, MD, PhD | ASCO 2023

CAR-T Therapy, CARTITUDE-1 ciltacabtagene autoleucel in RRMM Patients | Yi Lin, MD, PhD | ASCO 2023

Genomic Profiling in High-Risk Smoldering Myeloma | Benjamin Diamond, MD | ASH 2023

Genomic Profiling in High-Risk Smoldering Myeloma | Benjamin Diamond, MD | ASH 2023

$High-risk Vs Standard-Risk Relapsed/Refractory Myeloma | Charlotte Roundtable, May 4th, 2024$

High-risk Vs Standard-Risk Relapsed/Refractory Myeloma | Charlotte Roundtable, May 4th, 2024

Results of Bispecific Antibody Combination in Advanced Myeloma | Yael Cohen, MD | ASCO 2023

Results of Bispecific Antibody Combination in Advanced Myeloma | Yael Cohen, MD | ASCO 2023

Know Your Myeloma Therapy: What's Available for Maintenance Therapy?

Know Your Myeloma Therapy: What's Available for Maintenance Therapy?

Myeloma and Dexamethasone: Insights on Tapering, Dose Intensity, and Eye Health from New Research

Myeloma and Dexamethasone: Insights on Tapering, Dose Intensity, and Eye Health from New Research

HealthTree Podcast for Multiple Myeloma: Dr. Guido Tricot, University of Iowa

HealthTree Podcast for Multiple Myeloma: Dr. Guido Tricot, University of Iowa

Salt Lake Round Table - HealthTree Foundation for Multiple Myeloma

Salt Lake Round Table - HealthTree Foundation for Multiple Myeloma

© 2024 Tubidy